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Edited by Gianni CesareniAbstract In this report, we describe SH3P2, an SH3-domain
containing protein, as a novel Cbl-interacting molecule that is a
substrate of tyrosine kinase Src. We identiﬁed a speciﬁc
polyproline motif of Cbl responsible for binding of SH3P2 and
Src, and observed mutual sequestration of Src and SH3P2 from
monomer Cbl molecules. In adherent cells, SH3P2 associated
with Cbl and ﬁbrilar actin and was localized at focal contacts in
ﬁbroblasts as well as at the apical part of podosome rings in
diﬀerentiated osteoclasts. Our data implicate that SH3P2, a
novel component of adhesion sites, is involved in Cbl and Src-
mediated pathways.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The identiﬁcation of the proto-oncogene Casitas B-lineage
lymphoma (Cbl) has been a starting point for many exciting
discoveries that led to better understanding of how various
signaling pathways regulate biological responses in living cells
[1]. Thanks to its complex structure Cbl associates with re-
ceptor and non-receptor tyrosine kinases, mediates their
ubiquitination, and serves as a scaﬀolding molecule for many
signaling proteins. Cbl is a major substrate for Src family of
tyrosine kinases, and together with Pyk2 kinase has been
shown to be important for Src-mediated migration and func-
tion of osteoclasts [2,3]. Osteoclasts are multinucleated cells
that originate from monocyte-macrophage lineage and are
responsible for degradation of bone matrix [4]. They develop
highly dynamic adhesion structures called podosomes, which
contain Cbl and Src, as well as actin-associated proteins [5,6].
Cbl= osteoclasts are less motile and have decreased ability to
invade and resorb bone in vivo [7]. Moreover, expression of
truncated forms of Cbl inhibits formation of lamellipodia and
membrane ruﬄes [8].
Here, we show that SH3P2, a molecule composed of a short
proline-rich region, an SH3 domain and three ankyrin repeats,
functions as a novel Cbl-interacting partner in mammalian
cells. This protein has been originally cloned as SH3P2 in a
systematic screen for SH3-domain containing proteins from a
mouse embryo kcDNA library [9]. Additionally, a human* Corresponding author. Fax: +69-6301-5577.
E-mail address: dikic@biochem2.uni-frankfurt.de (I. Dikic).
0014-5793/$22.00  2004 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2004.03.100homolog has been cloned as osteoclast stimulating factor
(OSF) and shown to indirectly stimulate formation and ac-
tivity of osteoclasts [10]. We demonstrated that the SH3 do-
main of this molecule bound to a speciﬁc polyproline motif in
Cbl proteins, characterized the interactions between Cbl,
SH3P2 and Src that led to increased tyrosine phosphorylation
of SH3P2, and visualized the localization of SH3P2 in focal
contacts and podosomes.2. Materials and methods
2.1. Plasmids and products
Myc-tagged pCMVPLI vector expressing full size human SH3P2
(OSF) was provided by Sakamuri Reddy. R499A mutation was in-
troduced to HA-Cbl by PCR using QuickChange (Stratagene) proto-
col. c-Src constructs were kindly provided by Sara Courtneidge, Cbl
mutants by Wallace Y. Langdon. In DLZ-Cbl, a STOP codon was
introduced at the position 852. Anti-SH3P2 antibody was obtained
from a rabbit immunized with the peptide CRTLSNAEDYLDD-
EDSD. We used the following mouse monoclonal antibodies: anti-HA
(12CA5, Boehringer Mannheim), anti-Myc (9E10) and anti-phospho-
tyrosine (PY99) from Santa Cruz, anti-v-Src (Ab-1, Oncogene), anti-
FLAG (M2) and anti-vinculin (clone Vin-11-5) from Sigma. Rabbit
polyclonal anti-Cbl antibody was described previously [11]. Goat
polyclonal anti-GST antibody was from Pharmacia. FITC-conjugated
phalloidin and mouse ascites ﬂuid (clone AC-15) recognizing non-
muscle b-actin were from Sigma. Nocodazole (Sigma) was used at 2
lM. Cytochalasin D (Calbiochem) was used as described in Section 3.
2.2. Yeast two-hybrid screen
The screen was performed essentially in accordance with the
Matchmaker Two-Hybrid System 2 manual (Clontech) as described
previously [11]. The Y190 yeast strain and bait plasmid pYTH9 were
provided by Pontus Aspenstr€om.
2.3. Cell culture, transfections and immunoprecipitations
NIH3T3, HeLa and RAW 264.7 cells were from ATCC (Manassas,
VI). HEK293T cells were transiently transfected by calcium chloride
method, and 30 h after transfection cells were lysed in 1% Triton X-100
buﬀer containing inhibitors of proteases and phosphatases, and pro-
cessed with immunoprecipitation or GST-fusion binding followed by
SDS–PAGE and Western blotting as previously described [12].
2.4. Culturing of osteoclasts
Spleen cells of 6–8 week old male mice OF1 were seeded at 2500
cells/mm2 and were cultured for 8 days on coverslips in the diﬀeren-
tiation medium containing a-MEM medium (Life Technologies,
Carlsbad, CA), 10% of fetal calf serum (Hyclone), 20 ng/ml of M-CSF,
and 20 ng/ml of soluble recombinant RANK-L.
2.5. Indirect immunoﬂuorescence studies
NIH3T3 cells were ﬁxed in 4% paraformaldehyde in PBS for 20 min,
treated with NH4Cl (50 mM, 10 min), permeabilized in Triton X-100
(0.2%, 10 min) and blocked in 4% fetal calf serum. Preparations wereblished by Elsevier B.V. All rights reserved.
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antibody followed by incubation with TRITC- or FITC-anti-rabbit
antibodies, respectively (DAKO, Denmark). Images were taken with
digital camera from Zeiss microscope Axioplan 2. For confocal im-
aging of osteoclasts, the cells were processed as described [13] and
imaged with a Zeiss LSM 510 using 63 Plan Neo Fluor objective.
Coverslips were mounted in Prolong Antifade (Molecular Probes).
To prevent cross-contamination between ﬂuorochromes, each channel
was imaged sequentially using the multitrack recording module before
merging.3. Results
3.1. Identiﬁcation of SH3P2 as a binding partner of Cbl
The cDNA encoding SH3P2 protein was present in two out
of 11 double positive Cbl-binding clones in a yeast two-hybrid
screen with the human fetal brain cDNA library. Two other
clones contained adapter protein Nck, previously known to
interact with Cbl [14]. Both SH3P2 clones encoded the ﬁrst 114
out of 214 amino acids, that is the SH3 domain and a part of
the ﬁrst ankyrin repeat (Fig. 1A). This cDNA was used to
transform yeast clones expressing Cbl or Cbl fragments, and
the double transformants were subjected to the b-galactosidase
liquid culture assay. Result presented in Fig. 1B shows that theFig. 1. SH3P2 binds to proline-rich domain of Cbl. (A) Structure representa
PTB, phosphotyrosine binding domain; R, RING ﬁnger; PXXP proline-rich
substrate was used to calculate b-galactosidase activity in yeast. Yeast clones
were transformed with SH3P2 (amino acids 1–114) fused to GAL4-activation
SH3P2 were incubated with equal amounts of GST or indicated GST fusion p
transfected or overexpressing Myc-SH3P2 were probed with anti-SH3P2 ser
serum). After stripping, anti-Myc blot was performed to visualize the proteiproline-rich stretch of Cbl is required for binding to SH3P2.
This observation was conﬁrmed by aﬃnity precipitation ex-
periments in mammalian cells (Fig. 1C). In this and following
experiments, we used a rabbit polyclonal anti-SH3P2 antibody
that speciﬁcally recognizes a band of 28 kDa (Fig. 1D). When
resolved in SDS–PAGE gel, the recombinant Myc-tagged
SH3P2 has somewhat higher molecular mass than endogenous
SH3P2 from HEK293T cells (Fig. 1D).
3.2. Characterizing of proline-rich motif in Cbl responsible for
binding to SH3P2
In order to map the SH3P2 binding site within the proline-
rich stretch of Cbl, lysates from HEK293T cells expressing
carboxyl-terminal truncation constructs of Cbl were incubated
with full size SH3P2–GST fusion protein. The binding was
reduced in the case of 528-Cbl and was completely lost in the
case of 480-Cbl (Fig. 2A). The same pattern was obtained
when the isolated SH3 domain of SH3P2 or Src fused to GST
was used (not shown and Fig. 2A). The critical fragment in Cbl
(residues 480–528) contains PPVPPR sequence that has been
identiﬁed as SH3P2 ligand [9] and is a consensus site for
binding of SH3 domain of Src [15]. This sequence is conserved
among all mammalian Cbl members, Cbl, Cbl-b and Cbl-3, all
of which associated with SH3P2 in GST-binding assay (nottion of SH3P2 and Cbl. SH3, Src homology 3; ANK, ankyrin repeats;
sequences; LZ, leucine zipper. (B) Liquid culture assay using ONPG as
expressing Cbl or Cbl domains as fusion proteins with GAL4-DNA BD
domain. (C) Lysates from HEK293T cells transiently transfected with
roteins. (D) Equal amounts of total cell lysates from HEK293T mock-
um or serum from the same rabbit prior to immunization (preimmune
n level.
Fig. 2. Common motif in Cbl binds to SH3 domains of SH3P2 and Src.
(A) Lysates from HEK293T cells overexpressing the indicated car-
boxyl-terminal deletion constructs of Cbl were incubated with either
GST-conjugated SH3P2 or SH3 domain of Src. Upper panel: total cell
lysates, lower panel: protein complexes binding to GST-fusion pro-
teins. (B) Lysates from HEK293T cell transiently transfected with Cbl
or R499A-Cbl together with SH3P2 or Src were immunoprecipitated
and blotted as indicated.
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PPVPPR motif, did not co-precipitate SH3P2 nor Src
(Fig. 2B). Thus, we concluded that SH3 domains of both
proteins recognize the same polyproline motif in Cbl.
3.3. Formation of SH3P2–Cbl–Src complexes
A previous report about SH3P2 (OSF) suggested that Src
directly associates with SH3P2 [10], but despite all our at-
tempts we could not demonstrate the binding between the two
proteins. However, we observed that SH3P2 co-precipitates
with c-Src in the presence of overexpressed Cbl (Fig. 3A). It is
worth noting that the SH3P2 immunoprecipitates from Src-
expressing cells contained a number of phosphorylated pro-
teins, whose identity remains to be determined. Moreover, we
showed that SH3P2 is a substrate for Src-mediated tyrosine
phosphorylation in transiently transfected HEK293T cells
(Fig. 3A). Endogenous SH3P2 was also phosphorylated inv-Src transformed ﬁbroblasts (data not shown). Markedly,
overexpression of Cbl increased the level of SH3P2 phos-
phorylation by c-Src (Fig. 3A).
E3 activity of Cbl results in ubiquitination and degradation
of Src [16], and in order to stabilize the Cbl–Src complex we
used an ubiquitination-deﬁcient Cbl mutant (70Z-Cbl). As
expected, the binding between Src and 70Z-Cbl was stronger
than in the case of Cbl (Fig. 3B, bottom panel). Also, more
SH3P2 was phosporylated in cells expressing 70Z-Cbl in
comparison to cells expressing wild type Cbl (Fig. 3B, middle
panel). Interestingly, we could see that both Cbl proteins are
more phosphorylated by and associate stronger with c-Src in
the absence of overexpressed SH3P2 (Fig. 3B). This suggested
that SH3P2 competes with c-Src for binding to Cbl.
Dimerization of Cbl molecules could explain the seemingly
contradictory observations of binding competition on the one
hand and triple protein complex formation on the other. While
the expression of full size Cbl enabled the complex formation
between SH3P2 and Src, the deletion of carboxyl terminal LZ
domain of Cbl, which normally mediates homodimerization of
Cbl molecules [17], almost completely abrogated this eﬀect
(Fig. 3C, left panel). Notably, both SH3P2 and Src associate
with DLZ-Cbl and Cbl to the same degree (Fig. 3C, right pa-
nel). The detectable weak band of Src complexed with GST-
SH3P2 and DLZ-Cbl may be due to oligomerization of high
amounts of mutant Cbl via other proteins (i.e., CIN85) that
are able to bind and cluster Cbl molecules independently of the
LZ domain [11,18]. Based on the results shown in Figs. 2 and
3, we propose a hypothesis where SH3P2 and Src in a mutually
exclusive manner associate with individual Cbl molecules, that
in turn by forming oligomers can facilitate the triple protein
complex formation and phosphorylation of SH3P2 (Fig. 3D).
3.4. SH3P2 localization to actin structures
As shown in Fig. 4A, majority of SH3P2 was localized in the
nuclear and peri-nuclear region, but it was also found in dis-
tinct areas at the periphery of NIH3T3 ﬁbroblasts. In freshly
plated cells, these areas co-localized with actin and were
starting points for bunches of ﬁlamentous actin, which is a
characteristic of focal complexes and microspikes in lamelli-
podia (Fig. 4A, upper panel) [19,20]. In cells attached for 24 h,
SH3P2 was localized along the ends of stress ﬁbers, in the areas
close to the cell membrane (Fig. 4A, lower panel). In order to
check if SH3P2 interactions are dependent on intact actin cy-
toskeleton, we treated HeLa cells with cytochalasin D, known
to induce disassembly of F-actin [21]. As shown in Fig. 4B, in
untreated cells SH3P2 associated with actin, while treatment
with 3 and 10 lM cytochalasin D decreased the amount of
actin associated with SH3P2. Removing the polymerization-
blocking agent followed by 1-h incubation in normal media
reconstituted the initial level of SH3P2–actin complex
(Fig. 4B). Cytochalasin D treatment did not aﬀect the Cbl–
SH3P2 interaction. When the same amount of lysates was
immunoprecipitated with anti-Cbl antibodies, we could not
detect actin or SH3P2 in the precipitates (Fig. 4B), suggesting
that only small fraction of Cbl may be involved in binding
to SH3P2, and conﬁrming the speciﬁcity of SH3P2–actin
association.
3.5. SH3P2 localizes to podosomes in osteoclasts
In the light of previous implications of SH3P2 in osteo-
clast function, we analyzed the localization of this protein in
Fig. 3. The SH3P2–Cbl–Src complex. (A) HEK293T cells were transfected with SH3P2, c-Src, c-Src kinase-inactive (K)), and Cbl as indicated.
Protein expression is shown in TCL panel. Protein complexes associated with SH3P2 are shown in the right panel. The nitrocellulose membranes
were ﬁrst probed with an anti-phosphotyrosine antibody (PY) and subsequently stripped and re-probed with indicated antibodies. (B) HEK293T
were transiently transfected with the indicated cDNA constructs. Protein levels and phosphorylation pattern in total cell lysates (TCL) are shown in
the upper and middle panels, respectively. Amount of c-Src associated with Cbl proteins is shown in the immunoprecipitates with anti-HA antibody
(bottom panel). (C) Lysates from HEK293T cells expressing indicated cDNAs were incubated with GST fusion protein of SH3P2 and the bound
proteins are shown in the left panel. Immunoprecipitation experiment in cells overexpressing SH3P2, Src and either DLZ-Cbl or Cbl is shown in the
right panel. (D) Model of interactions within the SH3P2–Cbl–Src protein complex. Src and SH3P2 compete for binding to Cbl, and dimerization of
full size Cbl, impaired in the case of DLZ-Cbl, facilitates complex formation between all three molecules.
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the multiple nuclei and was also localized around podosomes
at the peripheral belt (Fig. 5A). Upon treatment with noco-
dazole, which depolymerizes microtubules necessary for
podosome distribution [22], SH3P2 remained associated with
individual podosomes even when the peripheral actin belt was
lost (data not shown). Vertical confocal sectioning of the
centers of individual podosomes revealed that SH3P2 is lo-
calized preferentially in their apical tips, that is the part facing
the inside of the cell (Fig. 5B, top panel). Cbl showed similar
distribution (Fig. 5B, middle panel), while vinculin was found
in the basal tip, oriented towards the plasma membrane
(Fig. 5B, bottom panel). Accuracy of spatial resolution in the
z-axis was conﬁrmed by taking images of test beads and by
using various ﬂuorophores to detect the same marker (not
shown). Cbl has been previously known to localize at the pe-
ripheral belt in osteoclasts [2], but the exact distribution in the
context of individual podosome rings was not shown before.4. Discussion
The recent identiﬁcation of numerous Cbl interacting part-
ners led to better understanding of Cbl’s role in regulating
diverse biological responses [1,23]. We found that a protein
known as SH3P2 is a novel Cbl binder, which in not subjected
to Cbl-mediated ubiquitination (data not shown), but can
serve as adaptor in Cbl functions in actin cytoskeleton.
Characterization of the binding between SH3P2 and Cbl led
us to identiﬁcation of a polyproline motif in Cbl recognized by
SH3 domains of SH3P2 and Src (Fig. 2). Although Src has
been reported previously to bind to SH3P2 (OSF) in overex-
pression experiments [10], we could detect the SH3P2–Src as-
sociation only in the presence of Cbl in the complex (Fig. 3A).
Even though we cannot completely exclude the possibility of
direct SH3P2–Src binding, our results rather indicate their
indirect association through complex formation with Cbl
molecules, and suggest concomitant and concentration-
Fig. 5. Distribution of SH3P2 in osteoclasts. (A) Murine RAW 264.7 cells were diﬀerentiated in vitro as described in Section 2. The merged picture of
SH3P2 and F-actin (phalloidin) is shown on the right. Scale bar, 20 lm. Enlarged image of the selected area of the podosome belt is shown in the left
bottom corner of each picture. (B) Zoom on podosomes scanned in the z-axis. The bottom of each image corresponds to the substratum underneath
cells. Scale bar, 2 lm.
Fig. 4. SH3P2 colocalizes with actin in adherent ﬁbroblasts. (A) NIH3T3 cells were allowed to attach to glass for 30 min or 24 h, ﬁxed and stained for
SH3P2 (red in merge) and F-actin (phalloidin, green in merge). Arrows point to selected places of colocalization; insets show details from cell
periphery with SH3P2–actin overlap. Scale bars correspond to 10 lm. (B) HeLa cells were treated with cytochalasin D: 3 lM for 30 min (lane 3), 10
lM for 30 min (lane 10) or 10 lM for 30 min followed by wash and 1 h incubation in normal medium (lane 10+). Lysates were immunoprecipitated
with anti-SH3P2 or anti-Cbl antibodies and blotted as indicated. TCL, total cell lysates.
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to Cbl (Fig. 4).
SH3P2 was found in a complex with F-actin (Fig. 4B) and
co-localized with dynamic actin ﬁlaments (Fig. 4A). In addi-
tion, we observed overlapping SH3P2 and vinculin distribution
in elongated focal contacts in ﬁbroblasts (not shown). SH3P2
was not binding to muscle F-actin in the actin precipitation
assay (not shown), so the interaction is indirect, and is prob-
ably mediated via the ankyrin repeats of SH3P2 (our unpub-
lished data).
Particular signiﬁcance of Cbl and Src proteins has been
demonstrated in osteoclasts, where Cbl acts downstream of c-
Src in a signaling pathway required for bone resorption [3]. In
osteoclasts, c-Src is associated with the ruﬄed border and co-
localizes with Cbl in vesicular structures [3,24]. We demon-
strated that SH3P2 together with Cbl is speciﬁcally distributed
around individual podosomes of osteoclasts. Unlike integrin-
associated proteins that localize to the distal side of podosome,
both SH3P2 and Cbl were found in the apical part (Fig. 5B),
which may suggest their role in downstream signaling rather
than in assembling of the adhesion complexes.
Importantly, our observations suggest dynamic and locally
regulated interaction and diﬀerential phosphorylation within
the triple protein complex. According to our hypothesis,
SH3P2 is constitutively associated with the Cbl pool localized
at the cell-substratum adhesion sites. Activation of integrins or
growth factor receptors induces Src-mediated phosphorylation
of Cbl, while opening of Src structure and enhanced binding of
Src to Cbl can result in phosphorylation of SH3P2 and its
dissociation from Cbl. In order to further elucidate the SH3P2
role in the context of cell physiology, we are currently
searching for other SH3P2 binding partners and are under-
taking the gene targeting approach to analyze phenotypes of
SH3P2 deﬁcient cells.
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